MedTrace Logo

Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery

NCT02513862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2016-11-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether autologous platelet rich plasma (APRP)is effective in reducing allogeneic blood transfusions during aortic surgery using deep hypothermic circulatory arrest.

Conditions

  • C.Surgical Procedure; Cardiac

Interventions

DEVICE

Autologous Platelet-Rich Plasma Harvest Technique

15 to 20 mL/kg of whole blood is collected before the administration of heparin from a large-bore central venous access,and is separated into red blood cells component and autologous platelet-rich plasma component by an autologous transfusion system(Sorin Group Electa Essential; Sorin Group Italia, Milan, Italy).

Sponsors & Collaborators

  • Hongwen Ji

    lead OTHER

Principal Investigators

  • Hongwen Ji, MD · Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC

  • Yongyuan Wang · Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-06-30
Completion
2016-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02513862 on ClinicalTrials.gov